65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79724D0059
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 54% complete
IDV ceiling
$2,250,000.00
Award type
Multiple award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

Marius Pharmaceuticals, Inc., a self-certified small disadvantaged business, was awarded a multiple-award Federal Supply Schedule contract by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs, effective February 1, 2024, through January 31, 2029. The contract, established under Schedule 65 IB for drugs, pharmaceuticals, and hematology-related products, carries a ceiling value of $2.25 million and includes a 2026 Public Law 102-585 pricing update provision. Under this Federal Supply Schedule, the VA Veterans Health Administration and other federal agencies may place orders for pharmaceutical products and supplies on an as-needed basis, utilizing the established pricing and terms without requiring individual competitive solicitations for each procurement action.

In support of this broader supply schedule, Marius Pharmaceuticals has also been awarded related Blanket Purchase Agreements, including a single-award BPA for the supply of KYZATREX, a pharmaceutical product utilized within VA Veterans Health Administration treatment programs. The KYZATREX BPA, representing the second option year exercise under master BPA 36E79724A0009 and awarded March 13, 2024, carries a ceiling value of $1,406.70 with performance extending through March 12, 2027. This BPA structure enables VA medical centers nationwide to procure KYZATREX without competitive bidding, streamlining the ordering process and providing expedited access to this pharmaceutical product across the VA's medical facility network. The combination of the Federal Supply Schedule contract and the specialized BPA vehicles positions Marius Pharmaceuticals as an established pharmaceutical supplier supporting veteran healthcare delivery.

IDV awards

IDV Agency Ceiling Awarded
36E79724A0009 BPA for kyzatrex National Acquisition Center (VA) $1,407

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00007 · 2026 public law 102-585 pricing update $0
Supplemental Agreement for work within scope P00005 · 2025 public law pricing updates $0
Supplemental Agreement for work within scope P00004 · Commercial changes perm FCP with special dist $0
Supplemental Agreement for work within scope P00003 · 65IB / (42-2A) / product addition / new package size at pro-rated (provisional) stage / single price / $0
Other Administrative Action P00002 · 65IB / 65IB / administrative change: update: IFF sales POC / $0
Supplemental Agreement for work within scope P00001 · 65IB / (42-2A) / economic price adjustment / BIG4 only $0
Original award $0

Quick answers

Who was awarded contract 36F79724D0059?

36F79724D0059 was awarded to Marius Pharmaceuticals, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on February 1, 2024.

How much is contract 36F79724D0059 worth?

36F79724D0059's own ceiling is $2,250,000.

Who can order from contract 36F79724D0059?

36F79724D0059 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79724D0059 part of a contract vehicle?

Yes. 36F79724D0059 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79724D0059 competed?

The extent of competition for 36F79724D0059 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV